Anatara Lifesciences Ltd (ASX:ANR)

Australia flag Australia · Delayed Price · Currency is AUD
0.0050
-0.0010 (-16.67%)
May 19, 2025, 3:58 PM AEST
-87.18%
Market Cap 1.28M
Revenue (ttm) 250.51K
Net Income (ttm) -1.93M
Shares Out 213.38M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,610,943
Average Volume 1,604,180
Open 0.0050
Previous Close 0.0060
Day's Range 0.0050 - 0.0060
52-Week Range 0.0040 - 0.0730
Beta 0.52
RSI 33.71
Earnings Date May 23, 2025

About Anatara Lifesciences

Anatara Lifesciences Ltd engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in animals and humans in Australia. The company offers Gastrointestinal ReProgramming, a proprietary formulation to address irritable bowel syndrome. It also provides Detach for the treatment of diarrhea disease in piglets. Anatara Lifesciences Ltd was incorporated in 2010 and is based in Adelaide, Australia. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol ANR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.